Skip to main content
AbbVie10-Q: Acquisition completed

AbbVie paid $10.6 billion primarily for Apogee acquisition and closed Arizona device facility

Source: Autobound Signal API · 112 signals tracked for AbbVie · updated

Get AbbVie's live signals in Claude or ChatGPT, or by API

AskWhat changed at AbbVie this week? Use Autobound signals for abbvie.com.

What happened

AbbVie made investing cash payments of $10.6 billion primarily related to the acquisition of Apogee and closed an agreement to acquire an Arizona device manufacturing facility in July 2026.

Source

SEC EDGARNov 3, 2026

Quarterly report (Form 10-Q)

AbbVie 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

Investing cash flows for the nine months ended September 30, 2026 included payments made for acquisitions of businesses, net of cash acquired of $10.6 billion primarily related to the acquisition of Apogee, other acquisitions and investments, net of cash acquired of $1.4 billion and capital expenditures of $888 mi

sec.gov/Archives/edgar/data/1551152/000155115226000037/abbv-20260930.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Sep 30, 2026
Fiscal year end
09/30
Filed
Nov 3, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$10.6B (payments made for acquisitions of businesses, net of cash acquired primarily related to the acquisition of Apogee)

Details

CIK
1551152
Accession number
0001551152-26-000037
Timeframe
Current year
Quarter
Q3
Filing year
2026
Period end date
Sep 30, 2026
Why it matters
Active integration needs
Signal category
Strategic

Topics and mentions

Regions named

  • Arizona

Extraction

Confidence
High
Relevance
85%
Sentiment
Neutral
Detected
Nov 10, 2026
signal_type
sec-10q
signal_subtype
acquisitionCompleted

Use this data

Get every 10-Q signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6135d164-d4cd-430c-93a8-0e84c3686c01 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "6135d164-d4cd-430c-93a8-0e84c3686c01",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-10T08:02:40.649+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "detail": "AbbVie made investing cash payments of $10.6 billion primarily related to the acquisition of Apogee and closed an agreement to acquire an Arizona device manufacturing facility in July 2026. This post-acquisition integration may create sales opportunities for integration consulting, regulatory compliance systems, and operations software.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "payments made for acquisitions of businesses, net of cash acquired primarily related to the acquisition of Apogee",
      "dollar_millions": 10600
    },
    "quarter": "Q3",
    "summary": "AbbVie paid $10.6 billion primarily for Apogee acquisition and closed Arizona device facility",
    "excerpts": "Investing cash flows for the nine months ended September 30, 2026 included payments made for acquisitions of businesses, net of cash acquired of $10.6 billion primarily related to the acquisition of Apogee, other acquisitions and investments, net of cash acquired of $1.4 billion and capital expenditures of $888 mi",
    "relevance": 0.85,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/abbv-20260930.htm",
    "filing_date": "2026-11-03",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic",
    "regions_mentioned": [
      "Arizona"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.